BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 29302878)

  • 1. Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome.
    Valeur J; Småstuen MC; Knudsen T; Lied GA; Røseth AG
    Dig Dis Sci; 2018 Feb; 63(2):429-436. PubMed ID: 29302878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols.
    Valeur J; Røseth AG; Knudsen T; Malmstrøm GH; Fiennes JT; Midtvedt T; Berstad A
    Digestion; 2016; 94(1):50-6. PubMed ID: 27487397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs.
    Bennet SMP; Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Öhman L; Simrén M
    Gut; 2018 May; 67(5):872-881. PubMed ID: 28416515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal microbiota fingerprint in subjects with irritable bowel syndrome responders to a low FODMAP diet.
    Valdez-Palomares F; Nambo-Venegas R; Uribe-García J; Mendoza-Vargas A; Granados-Portillo O; Meraz-Cruz N; Palacios-González B
    Food Funct; 2021 Apr; 12(7):3206-3218. PubMed ID: 33877245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders.
    Chumpitazi BP
    Curr Opin Gastroenterol; 2020 Mar; 36(2):147-154. PubMed ID: 31850930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet.
    Staudacher HM; Whelan K
    Proc Nutr Soc; 2016 Aug; 75(3):306-18. PubMed ID: 26908093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial.
    Erickson J; Korczak R; Wang Q; Slavin J
    Nutr J; 2017 May; 16(1):35. PubMed ID: 28545589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.
    Yan R; Murphy M; Genoni A; Marlow E; Dunican IC; Lo J; Andrew L; Devine A; Christophersen CT
    BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All that a physician should know about FODMAPs.
    Mehtab W; Agarwal A; Singh N; Malhotra A; Makharia GK
    Indian J Gastroenterol; 2019 Oct; 38(5):378-390. PubMed ID: 31802437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.
    Zahedi MJ; Behrouz V; Azimi M
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1192-1199. PubMed ID: 29159993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.
    Staudacher HM; Whelan K; Irving PM; Lomer MC
    J Hum Nutr Diet; 2011 Oct; 24(5):487-95. PubMed ID: 21615553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies.
    Varjú P; Farkas N; Hegyi P; Garami A; Szabó I; Illés A; Solymár M; Vincze Á; Balaskó M; Pár G; Bajor J; Szűcs Á; Huszár O; Pécsi D; Czimmer J
    PLoS One; 2017; 12(8):e0182942. PubMed ID: 28806407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Low-FODMAPS Diet on Irritable Bowel Syndrome Symptoms and Gut Microbiome.
    Su H; Li YT; Heitkemper MM; Zia J
    Gastroenterol Nurs; 2019; 42(2):150-158. PubMed ID: 30946302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
    Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
    Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome.
    Chumpitazi BP; Cope JL; Hollister EB; Tsai CM; McMeans AR; Luna RA; Versalovic J; Shulman RJ
    Aliment Pharmacol Ther; 2015 Aug; 42(4):418-27. PubMed ID: 26104013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised clinical trial: low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome.
    Laatikainen R; Koskenpato J; Hongisto SM; Loponen J; Poussa T; Hillilä M; Korpela R
    Aliment Pharmacol Ther; 2016 Sep; 44(5):460-70. PubMed ID: 27417338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs.
    Harvie RM; Chisholm AW; Bisanz JE; Burton JP; Herbison P; Schultz K; Schultz M
    World J Gastroenterol; 2017 Jul; 23(25):4632-4643. PubMed ID: 28740352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
    Schumann D; Klose P; Lauche R; Dobos G; Langhorst J; Cramer H
    Nutrition; 2018 Jan; 45():24-31. PubMed ID: 29129233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
    Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K
    Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome.
    Hustoft TN; Hausken T; Ystad SO; Valeur J; Brokstad K; Hatlebakk JG; Lied GA
    Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27747984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.